Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Venturi Mask Market size was over USD 3.65 billion in 2024 and is poised to exceed USD 13.05 billion by 2037, witnessing over 10.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of venturi mask is evaluated at USD 4.28 billion.
The reason behind the growth is impelled by the growing air pollution across the globe. The biggest environmental risk to human health is air pollution, which can lead to breathing problems such as shortness of breath and difficulty breathing. This may necessitate the use of venturi masks as they are low-flow masks that are used to give regulated oxygen concentrations.
According to estimates, global air pollution, results in over 5 million preventable deaths each year.
The rising technological advancements are believed to fuel the market growth. This has led to the development of more effective and user-friendly venturi masks. The improvement in design and materials have made them more comfortable and have allowed for remote monitoring of patients. Moreover, this would significantly increase the adoption rate of these devices.

Venturi Mask Sector: Growth Drivers and Challenges
Growth Drivers
- Rising Popularity of Sports – More sports activities could result in respiratory conditions which could lead to higher demand for venturi masks among sportspersons to manage the respiratory conditions.
More than 19% of Americans participated in sports and exercise every day in 2019. - Growing Geriatric Population- It is expected that the growing trend among the elderly to receive care for various diseases including respiratory conditions in home settings may increase the demand for venturi masks.
Lately, over 8% of the world's population, is over the age of 65, and by 2050 this figure is expected to rise to more than 15%.
Challenges
- Availability of Alternative Oxygen Delivery Devices – There are many other oxygen delivery devices such as anesthetic facemasks, respiratory drugs, endotracheal tubes, and nasal cannulas (aka nasal prongs) are cost-effective options that are easily available in the market. This may limit the adoption of a venturi mask as an oxygen delivery device.
- Regulatory Compliance
- Dearth of Awareness
Venturi Mask Segmentation
Application (COPD, Asthma, Pneumonia, Myocardial Infarction, Respiratory Distress Syndrome)
The COPD segment is estimated to hold around 40% share of the global Venturi Mask Market in the coming years owing to the growing consumption of cigarettes. The fifth leading cause of death globally is COPD which is typically brought on by cigarette smoking, since it contains a lot of hazardous compounds, and can lead to several abnormalities in the trachea, lung tissue, and pulmonary blood vessels. For a patient with COPD, where it's crucial to avoid over-oxygenating the patient, the Venturi mask is considered an ideal option since they reduce the risk of carbon dioxide retention with the partial pressure of oxygen (PO2) titration.
For instance, the annual consumption of cigarettes is over 4 trillion, which results in more than 6 million deaths and about US 1 trillion in economic losses.
End-User (Hospitals and clinics, Homecare, ASCs)
The homecare segment is set to garner a notable share of 39% shortly. After being released from the hospital, oxygen therapy is frequently still required for patients with chronic pulmonary disorders, and to deliver a controlled oxygen flow venturi masks are used which is set by healthcare professional to ensure correct oxygen delivery and avoid other complications.
Our in-depth analysis of the global market includes the following segments:
End-User |
|
Type |
|
Application |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportVenturi Mask Industry- Regional Synopsis
North American Market Forecast
North America industry is predicted to dominate majority revenue share of 40% by 2037. The yearly GDP growth rate in the United States is currently over 1% slower than healthcare costs, and the amount spent on healthcare in the US will amount to more than USD 6 trillion by 2028. As a result, this would improve access to medical facilities in the region, leading to more patients seeking treatment for respiratory conditions. This may lead to an increase in demand for venturi masks. The cost of healthcare in the United States in 2021 was over USD 4 trillion, or roughly USD 12,800 per person on average.
APAC Market Statistics
The APAC venturi mask market is estimated to be the second largest, during the forecast timeframe led by increasing awareness among patients regarding respiratory conditions. As a result, people in the region would not ignore their respiratory health and seek timely diagnoses of their conditions. Eventually, this would create more demand for venturi masks in the area.

Companies Dominating the Venturi Mask Landscape
- Becton, Dickinson and Co.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Airways Surgical Pvt. Ltd.
- Besmed Health Business Corp.
- Braun & Co. Ltd.
- Flexicare (Group) Ltd.
- For Care Enterprise Co. Ltd.
- JG Moriya
- Medline Industries Inc.
- Smiths Medical Inc.
- SunMed
- Fisher & Paykel Healthcare
- Terumo Corporation
In the News
- Flexicare (Group) Ltd. partnered with Premier, Inc. to offer an industry-leading selection of respiratory equipment, such as laryngeal mask airway, that improve patient care, and benefit from exclusive prices and conditions that Premier has already agreed upon.
- SunMed acquired Avanos Medical, Inc. purchased the respiratory health division of Avanos, which includes the BALLARD*, MICROCUFF*, and endOclear product lines to provide consumers with a one-stop shop for the most dependable and premium brands in anesthesia and respiratory care.
Author Credits: Radhika Pawar
- Report ID: 5140
- Published Date: Dec 20, 2024
- Report Format: PDF, PPT